Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9
Crossref DOI link: https://doi.org/10.1186/s12885-017-3526-8
Published Online: 2017-08-16
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Winther, Stine Braendegaard
Österlund, Pia
Berglund, Åke
Glimelius, Bengt
Qvortrup, Camilla
Sorbye, Halfdan
Pfeiffer, Per
Funding for this research was provided by:
Taiho Pharmaceutical (JP)
